Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Evaluation of the Tau Protein Binding Properties, Whole-Body Biodistribution and Safety of 18F-AV-1451 Injection in Healthy Volunteers and Cognitively Impaired Subjects

NCT04474405 is registered in ClinicalTrials.gov with Avid Radiopharmaceuticals as lead sponsor.

NCT NCT04474405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04474405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Evaluation of the Tau Protein Binding Properties, Whole-Body Biodistribution and Safety of 18F-AV-1451 Injection in Healthy Volunteers and Cognitively Impaired Subjects
Lead sponsor
Avid Radiopharmaceuticals
Phase
Phase 1
Overall status
Completed
Start date
August 16, 2013
Completion date
December 9, 2013
Enrollment
36 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease